| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
ICCC sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 205.7K | $1.20M | - | |
| CEO | 17.8K | $168.9K | - | |
| Dir | 4.7K | $22.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | Te Boekhorst Paul Francis Olivier59 | President and CEO | Buy | 8,000 | $9.50 | $75,960.00 | +81.8% | +1.3% | - | |
| Dec 3, 2025 | Te Boekhorst Paul Francis Olivier59 | President and CEO | Buy | 9,785 | $4.97 | $48,588.39 | New | +21.9% | - | |
| Nov 25, 2025 | Tomsche David Scott | Director | Buy | 3,266 | $4.76 | $15,554.33 | +221.6% | +36.8% | - | |
| Jun 12, 2025 | Gathagan Bryan K. | Director | Buy | 1,000 | $6.32 | $6,320.00 | New | -3.9% | - | |
| Jun 13, 2022 | Cunningham David | Director | Buy | 1,000 | $8.00 | $8,000.00 | +6.7% | -0.3% | -27.7% | |
| Mar 12, 2020 | Cunningham David | Director | Buy | 2,000 | $4.00 | $8,000.00 | +15.4% | - | - | |
| Mar 11, 2020 | Tomsche David Scott | Director | Buy | 4,600 | $4.28 | $19,688.00 | +5.7% | - | - | |
| Feb 27, 2020 | Tomsche David Scott | Director | Buy | 5,130 | $4.98 | $25,547.40 | +6.8% | - | - | |
| Aug 16, 2018 | Tomsche David Scott | Director | Buy | 3,000 | $6.67 | $20,010.00 | +4.1% | - | - | |
| Jul 27, 2017 | Pessin Norman H | See Explanation of Responses | Buy | 170,000 | $5.25 | $892,500.00 | New | - | - |